Literature DB >> 27753906

OS 02-06 PHYSIOLOGICAL REGULATION OF VASOMOTION BY INTRACELLULAR ATP-MEDIATED SYSTEM IN HUMAN ARTERY.

Young Chul Kim1, Dae Hoon Kim, Sang Eok Lee, Chan Hyung Kim, Woong Choi, Sang Jin Lee, Hyo-Yung Yun.   

Abstract

OBJECTIVE: Spontaneous oscillation of tone of blood vessel called vasomotion cause vessel to flow blood which is an oscillation of flow into an organ. Microcirculation is sensitive to hypoxic condition and metabolism but mechanism of vasomotion is still poorly understood. DESIGN AND
METHOD: Purpose: We studied involvement of metabolism-mediated regulation by intracellular ATP level of vasomotion in human gastric artery.
METHODS: Conventional contractile measuring system and Western blot were used.
RESULTS: Circular muscle of human gastric artery produced sustained tonic contraction of 1.0 ± 0.19 g by 50 mM high K (n = 36). Pinacidil (10 μM), which is known to activatorof ATP-sensitive K (KATP) channel inhibited vasomotion completely in a reversible manner. Inhibition of vasomotion by activators of KATP channel recovered by glibenclamide. Diazoxide (300 μM), cromakalim (10 μM) nicorandil (10 μM) which is known to activate KATP channel also completely blocked vasomotion in a glibenclamide sensitive manner. Inhibitory effect of these openers of KATP channel on serotonin and norepinephrine-induced contraction were also recoded in a glibenclmide-sensitive manner. In human artery, glucose-free condition which is elated metabolic changes inhibited vasomotion and it was recovered by glibenclamide. Finally, molecular subtypes of KATP channel was defined by Western blot in human artery.
CONCLUSIONS: Vasomotion of human gastroepiploic artery was inhibited by activation of specific subtypes of KATP channel and alteration of metabolism.

Entities:  

Year:  2016        PMID: 27753906     DOI: 10.1097/01.hjh.0000499981.55788.a6

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

Review 1.  Role of renal transporters and novel regulatory interactions in the TAL that control blood pressure.

Authors:  Lesley A Graham; Anna F Dominiczak; Nicholas R Ferreri
Journal:  Physiol Genomics       Date:  2017-04-07       Impact factor: 3.107

Review 2.  DOCA-Salt Hypertension: an Update.

Authors:  Tyler Basting; Eric Lazartigues
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

Review 3.  Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.

Authors:  Carlos M Ferrario; Adam E Mullick
Journal:  Pharmacol Res       Date:  2017-05-29       Impact factor: 7.658

4.  Association of the leptin-to-adiponectin ratio with metabolic syndrome in a sub-Saharan African population.

Authors:  Clarisse Noël A Ayina; Francky Teddy A Endomba; Samuel Honoré Mandengue; Jean Jacques N Noubiap; Laurent Serge Etoundi Ngoa; Philippe Boudou; Jean-François Gautier; Jean Claude Mbanya; Eugene Sobngwi
Journal:  Diabetol Metab Syndr       Date:  2017-09-05       Impact factor: 3.320

Review 5.  Small vessel disease to subcortical dementia: a dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit.

Authors:  Paola Caruso; Riccardo Signori; Rita Moretti
Journal:  Vasc Health Risk Manag       Date:  2019-08-07

6.  Hypoxic Conditions Promote Rhythmic Contractile Oscillations Mediated by Voltage-Gated Sodium Channels Activation in Human Arteries.

Authors:  Anne Virsolvy; Aurélie Fort; Lucie Erceau; Azzouz Charrabi; Maurice Hayot; Franck Aimond; Sylvain Richard
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.